Ginkgo Bioworks Holdings (DNA) Shares Issued (2020 - 2025)
Ginkgo Bioworks Holdings (DNA) reported Shares Issued of $9.2 million for Q4 2025, up 10795.24% on a YoY basis from N/an in Q4 2024, and down 11.29% quarter-over-quarter from $10.3 million in Q3 2025.
Ginkgo Bioworks Holdings (DNA) Shares Issued (2020 - 2025) Analysis & Trends
Ginkgo Bioworks Holdings has reported Shares Issued for 6 years, with the latest figure at $9.2 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Issued rose 10795.24% year-over-year to $9.2 million; the trailing twelve-month figure through Dec 2025 stood at $19.5 million (up 23077.38% YoY), and the FY2025 full-year result was $19.5 million, up 23077.38% from the prior year.
- Shares Issued for Q4 2025 stood at $9.2 million, down from $10.3 million in the prior quarter.
- The five-year high for Shares Issued was $99.2 million in Q4 2022, with the low at -$16.9 million in Q3 2022.
- Historically, Shares Issued has averaged $6.6 million across 5 years, with a median of $41000.0 in 2021.
- The largest YoY upside for Shares Issued was 141066.67% in 2022 against a maximum downside of 844850.0% in 2022.
- Ginkgo Bioworks Holdings' Shares Issued stood at $126000.0 in 2021, then soared by 78616.67% to $99.2 million in 2022, then sank by 100.08% to -$79000.0 in 2023, then soared by 206.33% to $84000.0 in 2024, then soared by 10795.24% to $9.2 million in 2025.
- The last three Shares Issued figures came in at $9.2 million (Q4 2025), $10.3 million (Q3 2025), and $84000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 5.40 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 27.00 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26,927.15 |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.15 Mn |
| Dec 31, 2025 | 9.15 Mn |
| Sep 30, 2025 | 10.32 Mn |
| Sep 30, 2025 | 10.32 Mn |
| Dec 31, 2024 | 84,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | -84,000.00 |
| Sep 30, 2024 | -84,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Dec 31, 2023 | -79,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |